https://www.sofi.com/invest/stock/TBPH/
Buy Theravance Biopharma Stock - TBPH Stock Price, Quote & News | SoFi
See real time price charts for TBPH stock, historical data, and recent news. Buy TBPH stock online with no commission fees.
price quotebuybiopharmastocknews
https://www.fool.com/quote/nasdaq/tbph/
Theravance Biopharma - TBPH - Stock Price & News | The Motley Fool
stock pricethe motleybiopharmanewsfool
https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-first-quarter-2021-financial-results-on-may-4-2021-301271792.html
Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021
/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and...
to reportfirst quarter
https://public.com/stocks/tbph/forecast-price-target
Theravance Biopharma (TBPH) Stock Forecast: Analyst Ratings, Predictions & Price Target 2026
6 analysts have given Theravance Biopharma (TBPH) a consensus rating of Buy while the Theravance Biopharma (TBPH) price prediction in 2026 is $19.83
stock forecastanalyst ratingsprice targetbiopharma
https://www.fiercebiotech.com/biotech/theravance-copd-drug-clears-safety-study-setting-up-nda
Theravance COPD drug clears safety study, setting up NDA | Fierce Biotech
Jul 20, 2017 - Theravance Biopharma and Mylan are still on course to file for approval of their nebulized chronic obstructive pulmonary disease (COPD) therapy in the fourth...
setting upcopddrugclearssafety
https://aijourn.com/theravance-biopharma-inc-reports-second-quarter-2025-financial-results-and-provides-corporate-update/
Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate...
Aug 12, 2025 - DUBLIN, Aug. 12, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and
second quarter